| 产品详情 |
| Edit |   |
|---|
| Product Name | LFM-A13 |
|---|
| Description | MW: 360. Purity ≥98% by TLC. Background: FM-A13 is a selective inhibitor of Bruton's tyrosine kinase (BTK) - IC??'s = 2.5 uM (recombinant BTK) and 17.2 uM (human BTK). It has also been shown to inhibit Polo-like kinase (PLK) (IC?? = 61 uM for human PLK3). It displays no activity (concentrations up to 278 uM) at JAK1, JAK3, HCK, EGFRK and IRK2 or CDK1-3, CHK1, IKK, MAPK1, SAPK2a and ten tyrosine kinases. |
|---|
| Size | 5 mg, 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [(2Z) -2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide] |
|---|
| Gene, Accession, CAS # | CAS: 244240-24-2 |
|---|
| Catalog # | MBS842997 |
|---|
| Price | |
|---|
| Order / More Info | LFM-A13 from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|